Oncology Medical News about Pulmonary neuroendocrine tumors

Become a Member Today!
Register

Most Viewed Abstracts

1. Report Shows Shift in Starting Salaries for Physicians

2. Recommendations on the use of 18F-FDG PET in oncology

3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials

4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer

5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Pulmonary neuroendocrine/carcinoid tumors
Cancer, 07/01/09

Bertino EM et al. - Although conventional cytotoxic therapy has not been reported to demonstrate much promise in this entity over the past 4 decades, newer molecular targeted agents including those that targeted angiogenesis and the mammalian target of rapamycin (mTOR) pathway have shown encouraging results in early phase trials for advanced carcinoid tumors.

<< Previous
Expression profiling of ependymomas unravels localization and...

Next >>
Cancer treatment adherence among low-income women with breast or...

A Comparison of 68Ga-DOTATATE and 18F-FDG PET/CT in Pulmonary Neuroendocrine Tumors
The Journal of Nuclear Medicine, 11/16/09 Relevance Score: 79%

Pulmonary Crystal-Storing Histiocytoma in a Patient Without a Lymphoproliferative Disorder
The American Journal of the Medical Sciences, 11/13/09 Relevance Score: 67%

Miscellaneous Cancers (Lung, Thyroid, Renal Cancer, Myeloma, and Neuroendocrine Tumors): Role of SPECT and PET in Imaging Bone Metastases
Seminars in Nuclear Medicine, 10/14/09 Relevance Score: 67%

Liver Metastases of Neuroendocrine Tumors: Treatment With Hepatic Transarterial Chemotherapy Using Two Therapeutic Protocols
American Journal of Roentgenology, 10/08/09 Relevance Score: 66%

Pulmonary Nodulosis and Aseptic Granulomatous Lung Disease Occurring in Patients with Rheumatoid Arthritis Receiving Tumor Necrosis Factor-alpha-Blocking Agent: A Case Series
Journal of Rheumatology, 10/07/09 Relevance Score: 66%